PharmiWeb57m
Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free ...
PharmiWeb1h
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
PartnershipLonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) 24.09.2024 / 14:00 CET/CEST Lonza to manufacture CASGEVY®, the world’s first ...
PharmiWeb1h
Cloud Storage Security Names Kevin Hunt as Chief Technology Officer
Former Microsoft Technology Leader Will Oversee the Enhancement of the Company's Innovative Data Security Solutions SALT LAKE ...
PharmiWeb1h
Ensysce Biosciences Presenting at Upcoming Meetings
New Data on Opioid Use Disorder Program at Society for Neuroscience Meeting ~~ Ensysce CEO Invited Expert Speaker at ...
PharmiWeb1h
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States
PRINCETON, NJ / ACCESSWIRE / September 24, 2024 / Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening ...
PharmiWeb1h
CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace
Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life Sciences unprecedented exposure on a global retail ...
PharmiWeb1h
ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research
South Florida Biotech Company Seeks To Expand Its Research Program Into Phase 2 Clinical TrialsZEO ScientifiX, Inc. ("ZEO" or ...
PharmiWeb2h
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA™ abuse deterrent transdermal technologyNutriband ...
PharmiWeb5h
Bioz and Boston BioProducts Introduce Advanced Badges and Content Hub to Transform Research Discovery
PALO ALTO, CA / ACCESSWIRE / September 24, 2024 / Bioz, Inc., a trailblazer in AI-driven research solutions, is proud to announce a transformative partnership with Boston BioProducts, a leading ...
PharmiWeb7h
Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Study resultsMarinomed Biotech AG reports positive clinical results for unique Carragelose eye drops 24.09.2024 / 07:45 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb15h
Cenna Biosciences Receives NIH NIA Phase II SBIR A…
LA JOLLA, CA / ACCESSWIRE / September 23, 2024 / Cenna Biosciences Inc., a privately-held biopharmaceutical company based in La Jolla, California, and focused on developing novel treatments for ...
PharmiWeb17h
OrtoWay-US Inc. Announces Granting of U.S. Patent for OrtoWell(R) Distractor System for Spinal Surgery Corpectomy
FDA-approved system enables safe, smooth and accurate fixationDifferentiated hydraulic design gives spinal surgeons greater ...